Literature DB >> 18054955

Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury.

Yousuke T Horikawa1, Hemal H Patel, Yasuo M Tsutsumi, Michelle M Jennings, Michael W Kidd, Yasuko Hagiwara, Yoshihiro Ishikawa, Paul A Insel, David M Roth.   

Abstract

Volatile anesthetics protect the heart from ischemia/reperfusion injury but the mechanisms for this protection are poorly understood. Caveolae, sarcolemmal invaginations, and caveolins, scaffolding proteins in caveolae, localize molecules involved in cardiac protection. We tested the hypothesis that caveolae and caveolins are essential for volatile anesthetic-induced cardiac protection using cardiac myocytes (CMs) from adult rats and in vivo studies in caveolin-3 knockout mice (Cav-3(-/-)). We incubated CM with methyl-beta-cyclodextrin (MbetaCD) or colchicine to disrupt caveolae formation, and then exposed the myocytes to the volatile anesthetic isoflurane (30 min, 1.4%), followed by simulated ischemia/reperfusion (SI/R). Isoflurane protected CM from SI/R [23.2+/-1.6% vs. 71.0+/-5.8% cell death (assessed by trypan blue exclusion), P<0.001] but this protection was abolished by MbetaCD or colchicine (84.9+/-5.5% and 64.5+/-6.1% cell death, P<0.001). Membrane fractionation by sucrose density gradient centrifugation of CM treated with MbetaCD or colchicine revealed that buoyant (caveolae-enriched) fractions had decreased phosphocaveolin-1 and caveolin-3 compared to control CM. Cardiac protection in vivo was assessed by measurement of infarct size relative to the area at risk and cardiac troponin levels. Isoflurane-induced a reduction in infarct size and cardiac troponin relative to control (infarct size: 26.5%+/-2.6% vs. 45.3%+/-5.4%, P<0.01; troponin: 27.7+/-4.4 vs. 77.7+/-11.8 ng/ml, P<0.05). Isoflurane-induced cardiac protection was abolished in Cav-3(-/-) mice (infarct size: 53.4%+/-6.1% vs. 53.2%+/-3.5%, P<0.01; troponin: 102.1+/-22.3 vs. 105.9+/-8.2 ng/ml, P<0.01). Isoflurane-induced cardiac protection is thus dependent on the presence of caveolae and the expression of caveolin-3. We conclude that caveolae and caveolin-3 are critical for volatile anesthetic-induced protection of the heart from ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054955      PMCID: PMC2701396          DOI: 10.1016/j.yjmcc.2007.10.003

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  50 in total

Review 1.  Caveolins: structure and function in signal transduction.

Authors:  Wanda M Krajewska; Izabela Masłowska
Journal:  Cell Mol Biol Lett       Date:  2004       Impact factor: 5.787

Review 2.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

Review 3.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

4.  Role of 12-lipoxygenase in volatile anesthetic-induced delayed preconditioning in mice.

Authors:  Yasuo M Tsutsumi; Hemal H Patel; Diane Huang; David M Roth
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-28       Impact factor: 4.733

5.  Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species.

Authors:  Lynda M Ludwig; Dorothee Weihrauch; Judy R Kersten; Paul S Pagel; David C Warltier
Journal:  Anesthesiology       Date:  2004-03       Impact factor: 7.892

6.  Insulin resistance in skeletal muscles of caveolin-3-null mice.

Authors:  Jin Oshikawa; Koji Otsu; Yoshiyuki Toya; Takashi Tsunematsu; Raleigh Hankins; Jun-ichi Kawabe; Susumu Minamisawa; Satoshi Umemura; Yasuko Hagiwara; Yoshihiro Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

7.  Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate.

Authors:  O Feron; C Dessy; D J Opel; M A Arstall; R A Kelly; T Michel
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

8.  Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart.

Authors:  J E Schultz; A K Hsu; G J Gross
Journal:  Circ Res       Date:  1996-06       Impact factor: 17.367

9.  Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning.

Authors:  Rafaela da Silva; Thomas Grampp; Thomas Pasch; Marcus C Schaub; Michael Zaugg
Journal:  Anesthesiology       Date:  2004-01       Impact factor: 7.892

10.  The role of three cytoplasmic fibers in BHK-21 cell motility. I. Microtubules and the effects of colchicine.

Authors:  R D Goldman
Journal:  J Cell Biol       Date:  1971-12       Impact factor: 10.539

View more
  53 in total

1.  Caveolin modulates integrin function and mechanical activation in the cardiomyocyte.

Authors:  Sharon Israeli-Rosenberg; Chao Chen; Ruixia Li; Daniel N Deussen; Ingrid R Niesman; Hideshi Okada; Hemal H Patel; David M Roth; Robert S Ross
Journal:  FASEB J       Date:  2014-11-03       Impact factor: 5.191

Review 2.  Non-canonical roles for caveolin in regulation of membrane repair and mitochondria: implications for stress adaptation with age.

Authors:  Jan M Schilling; Hemal H Patel
Journal:  J Physiol       Date:  2015-10-14       Impact factor: 5.182

Review 3.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

4.  Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.

Authors:  Youn Wook Chung; Claudia Lagranha; Yong Chen; Junhui Sun; Guang Tong; Steven C Hockman; Faiyaz Ahmad; Shervin G Esfahani; Dahae H Bae; Nazari Polidovitch; Jian Wu; Dong Keun Rhee; Beom Seob Lee; Marjan Gucek; Mathew P Daniels; Christine A Brantner; Peter H Backx; Elizabeth Murphy; Vincent C Manganiello
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-15       Impact factor: 11.205

5.  Hypoxic preconditioning promotes the translocation of protein kinase C ε binding with caveolin-3 at cell membrane not mitochondrial in rat heart.

Authors:  Hongmei Yu; Zhaogang Yang; Su Pan; Yudan Yang; Jiayi Tian; Luowei Wang; Wei Sun
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection.

Authors:  Louise E See Hoe; Jan M Schilling; Emiri Tarbit; Can J Kiessling; Anna R Busija; Ingrid R Niesman; Eugene Du Toit; Kevin J Ashton; David M Roth; John P Headrick; Hemal H Patel; Jason N Peart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-25       Impact factor: 4.733

7.  Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins.

Authors:  Junhui Sun; Mark J Kohr; Tiffany Nguyen; Angel M Aponte; Patricia S Connelly; Shervin G Esfahani; Marjan Gucek; Mathew P Daniels; Charles Steenbergen; Elizabeth Murphy
Journal:  Antioxid Redox Signal       Date:  2011-08-11       Impact factor: 8.401

Review 8.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

Review 9.  Membrane rafts and caveolae in cardiovascular signaling.

Authors:  Paul A Insel; Hemal H Patel
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

10.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.